Kirsch, B., DuBois, J. and Chadha, D. 2019. A Multi-Center, Open-Label Study to Assess Pharmacokinetics (PK), Safety and Tolerability of Sofpironium Bromide Gel, 15% Applied Topically to Children and Adolescents, ≥9 to <17 Years of Age, with Axillary Hyperhidrosis. SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S54. DOI:https://doi.org/10.25251/skin.3.supp.54.